JP Morgan Chase
NTUS

JP Morgan Chase’s Natus Medical Inc NTUS Stock Holding History

JP Morgan Chase’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-290,540
Closed -$9.52M – 7177
2022
Q2 		$9.52M Sell
290,540
-345,395
-54% -$10.9M ﹤0.01% 2209
2022
Q1 		$16.7M Sell
635,935
-47,194
-7% -$1.15M ﹤0.01% 1922
2021
Q4 		$16.2M Buy
683,129
+120,881
+21% +$2.98M ﹤0.01% 1996
2021
Q3 		$14.1M Sell
562,248
-57,290
-9% -$1.46M ﹤0.01% 2073
2021
Q2 		$16.1M Buy
619,538
+272,830
+79% +$7.42M ﹤0.01% 2031
2021
Q1 		$8.88M Buy
346,708
+34,048
+11% +$873K ﹤0.01% 2470
2020
Q4 		$6.27M Sell
312,660
-36,582
-10% -$716K ﹤0.01% 2612
2020
Q3 		$5.9M Sell
349,242
-41,214
-11% -$779K ﹤0.01% 2428
2020
Q2 		$8.52M Sell
390,456
-70,664
-15% -$1.62M ﹤0.01% 2017
2020
Q1 		$10.7M Buy
461,120
+361,181
+361% +$10.5M ﹤0.01% 1688
2019
Q4 		$3.3M Sell
99,939
-34,958
-26% -$1.12M ﹤0.01% 3017
2019
Q3 		$4.29M Buy
134,897
+115,793
+606% +$3.38M ﹤0.01% 2827
2019
Q2 		$483K Buy
19,104
+4,030
+27% +$103K ﹤0.01% 4260
2019
Q1 		$383K Sell
15,074
-51,428
-77% -$1.53M ﹤0.01% 4336
2018
Q4 		$2.26M Buy
66,502
+32,242
+94% +$1.05M ﹤0.01% 3194
2018
Q3 		$1.22M Sell
34,260
-33,575
-49% -$1.19M ﹤0.01% 3794
2018
Q2 		$2.34M Sell
67,835
-158,044
-70% -$5.54M ﹤0.01% 3302
2018
Q1 		$7.6M Buy
225,879
+23,315
+12% +$738K ﹤0.01% 2225
2017
Q4 		$7.74M Buy
202,564
+164,797
+436% +$6.58M ﹤0.01% 2320
2017
Q3 		$1.41M Buy
37,767
+4,457
+13% +$157K ﹤0.01% 3342
2017
Q2 		$1.24M Sell
33,310
-56,558
-63% -$2.04M ﹤0.01% 3311
2017
Q1 		$3.53M Sell
89,868
-125,265
-58% -$4.7M ﹤0.01% 2664
2016
Q4 		$7.49M Buy
215,133
+84,691
+65% +$3.32M ﹤0.01% 2133
2016
Q3 		$5.13M Buy
130,442
+32,877
+34% +$1.31M ﹤0.01% 2237
2016
Q2 		$3.69M Buy
97,565
+1,215
+1% +$40.7K ﹤0.01% 2476
2016
Q1 		$3.7M Buy
96,350
+66,933
+228% +$2.49M ﹤0.01% 2377
2015
Q4 		$1.41M Buy
29,417
+2,744
+10% +$127K ﹤0.01% 2947
2015
Q3 		$1.05M Sell
26,673
-8,657
-25% -$368K ﹤0.01% 3074
2015
Q2 		$1.5M Sell
35,330
-1,918
-5% -$76.4K ﹤0.01% 3071
2015
Q1 		$1.47M Buy
37,248
+8,881
+31% +$327K ﹤0.01% 3021
2014
Q4 		$1.02M Buy
28,367
+5,105
+22% +$171K ﹤0.01% 3331
2014
Q3 		$686K Sell
23,262
-51,437
-69% -$1.42M ﹤0.01% 3529
2014
Q2 		$1.88M Sell
74,699
-127,331
-63% -$3.15M ﹤0.01% 2568
2014
Q1 		$5.21M Sell
202,030
-46,755
-19% -$1.18M ﹤0.01% 2060
2013
Q4 		$5.6M Buy
248,785
+8,880
+4% +$171K ﹤0.01% 2102
2013
Q3 		$3.4M Buy
239,905
+152,745
+175% +$2.04M ﹤0.01% 2440
2013
Q2 		$1.19M Buy
+87,160
New +$1.19M ﹤0.01% 3142

Other funds holding NTUS

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

JP Morgan Chase's NTUS Position: Q3 2022 in Review

JP Morgan Chase sold out of Natus Medical Inc (NTUS) in Q3 2022, closing a stake of 290,540 shares — an estimated $9.52M sold.

JP Morgan Chase first reported a position in NTUS in Q2 2013 and held it in 37 quarters. The position peaked at $16.7M in Q1 2022. 1 fund tracked by Wall St. Rank holds NTUS as of Q3 2022.

  • JP Morgan Chase reported no remaining Natus Medical Inc position as of Q3 2022 after selling out during the quarter.
  • JP Morgan Chase sold 290,540 Natus Medical Inc shares in Q3 2022, an estimated $9.52M.
  • JP Morgan Chase first reported a position in Natus Medical Inc in Q2 2013 and held it in 37 quarters.
  • JP Morgan Chase's Natus Medical Inc position peaked at $16.7M in Q1 2022.
  • 1 fund tracked by Wall St. Rank held Natus Medical Inc as of Q3 2022.

Based on JP Morgan Chase's 13F filing for Q3 2022, filed 14 Nov 2022.